http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok#Head http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok#assertion http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok#provenance http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok#pubinfo http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok#assertion http://purl.obolibrary.org/obo/MONDO_0002046 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/MONDO_0002046 http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/DRUGBANK:DB00657 http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok#association http://www.w3.org/2000/01/rdf-schema#label The nicotinic-acetylcholine receptor (nAchR)- antagonist mecamylanine has been found to reduce the stimulus produced by ethanol in human lab studies. The nAchR-antagonist varenicline has also displayed positive effect in reducing alcohol consumption in multiple clinical trials. In this 12- week double-blind trial, participants (n 1⁄4 126) were randomized to either mecamylamine (10 mg daily) or placebo. No medication effect was found for reducing heavy drinking days (HDD) or alcohol craving. Smoking status had no effect on the results. The authors suggest that broad-spectrum nAchR-antagonists may not be beneficial in treat- ing AUD http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok#association https://w3id.org/biolink/vocab/publications https://pubmed.ncbi.nlm.nih.gov/30973369 http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok#association https://w3id.org/biolink/vocab/relation https://w3id.org/um/neurodkg/OffLabelIndication https://identifiers.org/DRUGBANK:DB00657 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok#provenance http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok#assertion http://www.w3.org/ns/prov#generatedAtTime 2021-08-24T17:09:05.80667 http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok#pubinfo http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok#sig http://purl.org/nanopub/x/hasSignature LWyPq6TCC7JRCYWpQrKGFxo+G4kWqOnqMpbnqgNlAgJwkcKSXNDhbnesKo2LYlf00KPsejPghpfPiYVKeoR5YPQRrRLmAubvQExSRkPRfMPIokScBAgClXgg9HIz8tX3iI8vEGFu1OpzF3/7retE0Igg5lA0rJV6tcayXLIPof0= http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok http://purl.org/dc/terms/created 2021-08-25T18:14:02.481+02:00 http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok http://purl.org/dc/terms/creator https://orcid.org/0000-0002-7641-6446 http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok http://purl.org/nanopub/x/supersedes http://purl.org/np/RAHTMDPT6XyaNv0R67W6y6nJwpAEHJF9fWpEuYXfoUtgo http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok http://www.w3.org/ns/prov#generatedAtTime 2021-08-24T17:09:05.80667 http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-7641-6446 http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RAcm8OurwUk15WOgBM9wySo-T3a5h6as4K8YR5MBrrxUc http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RA2vCBXZf-icEcVRGhulJXugTGxpsV5yVr9yqCI1bQh4A http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAjpBMlw3owYhJUBo3DtsuDlXsNAJ8cnGeWAutDVjuAuI http://purl.org/np/RA2plesgmHbxVeX02hRRQwCqTxProxTT8hq58ZwtSfWok https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY